Cargando…
Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass
Serum autoantibodies against the p53 protein (p53 AAb) were analysed with a newly developed enzyme-linked immunosorbent assay (ELISA) based on highly purified and renatured p53. In a hospital-based cohort study, preoperative sera from 113 patients with ovarian cancer, 15 patients with borderline tum...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2000
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2408792/ https://www.ncbi.nlm.nih.gov/pubmed/11044359 http://dx.doi.org/10.1054/bjoc.2000.1446 |